Source: FE Investegate

Strongbridge Biopharma: Morgan Stanley Smith : Form 8.3 -STRONGBRIDGE BIOPHARMA PLC

10:32 AM: Form 8.3 -STRONGBRIDGE BIOPHARMA PLC

Read full article »
Strongbridge Biopharma's Competitors | Strongbridge Biopharma's News | Strongbridge Biopharma's Financials
Stay up-to-date with the latest news on Strongbridge Biopharma
Est. Annual Revenue
$25-100M
Est. Employees
25-100
John H. Johnson's photo - CEO of Strongbridge Biopharma

CEO

John H. Johnson

CEO Approval Rating

84/100

Read more
Stay up-to-date with the latest news on Strongbridge Biopharma